Regina Barragan-Carrillo, MD, discusses findings from an analysis of global RCC clinical trial availability in high- vs low-to-middle–income countries.
Regina Barragan-Carrillo, MD
Advertisement
Regina Barragan-Carrillo, MD, is a postdoctoral research fellow at City of Hope Comprehensive Cancer Center.
Articles by Regina Barragan-Carrillo, MD
Advertisement
Latest Updated Articles
Dr Barragan-Carrillo on Global Disparities in Clinical Trial Availability in RCCPublished: March 5th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5